As discussed in a previous paragraph, the transcription factors Sox2 and Oct4 are activated in GSCs promoting glioma cell stemness and stimulating several mechanisms leading to innate and adaptive immune response inhibition (38). The gene discussed is SOX2; the disease is glioma.